RPS6KB1 and lung cancer: Together these results indicate that miR-200b is capable of directly targeting p70S6K1, thereby suppressing lung cancer cell proliferation and invasion, suggesting that this miR-200b/p70S6K1 pathway could represent a novel mechanism governing tumor metastasis and may also serve as a valuable prognostic marker of disease progression.